MARIOTTINI, ALICE
MARIOTTINI, ALICE
Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA)
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance
2022 Mariottini A, Repice AM, Barilaro A, Massacesi L
Antibody-mediated cell depletion therapies in multiple sclerosis
2022 Mariottini, Alice; Muraro, Paolo A; Lünemann, Jan D
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case Series
2021 Nicholas R.S.; Rhone E.E.; Mariottini A.; Silber E.; Malik O.; Singh-Curry V.; Turner B.; Scalfari A.; Ciccarelli O.; Sormani M.P.; Olavarria E.; Mehra V.; Gabriel I.; Kazmi M.A.; Muraro P.
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis
2022 Mariottini, Alice; Bulgarini, Giovanni; Forci, Benedetta; Innocenti, Chiara; Mealli, Fabrizia; Mattei, Alessandra; Ceccarelli, Chiara; Repice, Anna Maria; Barilaro, Alessandro; Mechi, Claudia; Saccardi, Riccardo; Massacesi, Luca
Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic management
2023 Lotti, Antonio; Barilaro, Alessandro; Mariottini, Alice; Vannozzi, Lorenzo; Piergentili, Marco; Fainardi, Enrico; Massacesi, Luca
Challenges in Diagnosis of COVID-19 Pneumonia under Ocrelizumab and De-Risking Strategies in Multiple Sclerosis—The Elephant Is (Still) in the Room
2024 Mariottini, Alice; Lotti, Antonio; Damato, Valentina; Massacesi, Luca
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions
2021 Antonio Farina, Alice Mariottini, Federica Azzolini, Claudia Mechi, Anna Maria Repice, Alessandro Barilaro, Luca Massacesi
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study
2019 Pasca, M; Forci, B; Mechi, C; Mariottini, A; Barilaro, A; Massacesi, L; Repice, AM
CNS inflammation during relapsing remitting multiple sclerosis (RRMS): a molecular and cellular analysis of ex vivo CSF T lymphocyte expansions
2013 Galante, A; Bonechi, E; Mariottini, A; Aldinucci, A; Biagioli, T; Mechi, C; Repice, A; Massacesi, L; Ballerini, C
Comparative efficacy of subcutaneous versus intravenous natalizumab on annualized relapse rate: a post-hoc analysis of the REFINE study
2024 Mariottini, Alice; Mealli, Fabrizia; Mattei, Alessandra; Massacesi, Luca
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation
2019 Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis
2024 Mariottini, Alice; Nozzoli, Chiara; Carli, Ilaria; Landi, Filippo; Gigli, Valentina; Repice, Anna Maria; Ipponi, Alessandra; Cecchi, Michele; Boncompagni, Riccardo; Saccardi, Riccardo; Massacesi, Luca
COVID-19 in patients with aggressive MS treated with aHSCT: a multi-center study
2021 E. Sbragia, A. Mariottini, M. Capobianco, S. Martire, L. Moiola, M.P. Amato, L. Massacesi, G. Mancardi, G. Boffa, M. Inglese
Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?
2024 Bellanca, Carlo Maria Maria; Augello, Egle; Mariottini, Alice; Bonaventura, Gabriele; Cognata, Valentina La; Benedetto, Giulia Di; Cantone, Anna Flavia; Attaguile, Giuseppe; Mauro, Rosaria Di; Cantarella, Giuseppina; Massacesi, Luca; Bernardini, Renato
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports.
2017 Forci, B; Mariottini, A; Mechi, C; Massacesi, L; Repice, A.
Early Morbidity of Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis- A Real World Experience
2021 Varun Mehra, Maria Cuadrado, Elijah Rhone, Alice Mariottini, Victoria Williams, Sarah Ware, Paolo Muraro, Antonio Pagliuca, Victoria Potter, Eli Silber, Majid Kazmi
Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis
2022 Mariottini A, Bertozzi A, Marchi L, Di Cristinzi M, Mechi C,Barilaro A,Massacesi L,Repice A.
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation
2023 Alice Mariottini, Antonio Lotti, Chiara Innocenti, Anna Maria Repice , Chiara Nozzoli , Riccardo Boncompagni , Enrico Fainardi , Riccardo Saccardi, Luca Massacesi
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis
2019 Mariottini, A; Filippini, S; Di Tullio, MG; Forci, B; Innocenti, C; Barilaro, A; Fani, A; Saccardi, R; Massacesi, L; Repice, AM
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments
2019 Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Falcini, M; Palumbo, P; Massacesi, L; Repice, AM
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance | 2022 | Mariottini A, Repice AM, Barilaro A, Massacesi L | |
| Antibody-mediated cell depletion therapies in multiple sclerosis | 2022 | Mariottini, Alice; Muraro, Paolo A; Lünemann, Jan D | |
| Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case Series | 2021 | Nicholas R.S.; Rhone E.E.; Mariottini A.; Silber E.; Malik O.; Singh-Curry V.; Turner B.; Scalfari A.; Ciccarelli O.; Sormani M.P.; Olavarria E.; Mehra V.; Gabriel I.; Kazmi M.A.; Muraro P. | |
| Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis | 2022 | Mariottini, Alice; Bulgarini, Giovanni; Forci, Benedetta; Innocenti, Chiara; Mealli, Fabrizia; Mattei, Alessandra; Ceccarelli, Chiara; Repice, Anna Maria; Barilaro, Alessandro; Mechi, Claudia; Saccardi, Riccardo; Massacesi, Luca | |
| Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic management | 2023 | Lotti, Antonio; Barilaro, Alessandro; Mariottini, Alice; Vannozzi, Lorenzo; Piergentili, Marco; Fainardi, Enrico; Massacesi, Luca | |
| Challenges in Diagnosis of COVID-19 Pneumonia under Ocrelizumab and De-Risking Strategies in Multiple Sclerosis—The Elephant Is (Still) in the Room | 2024 | Mariottini, Alice; Lotti, Antonio; Damato, Valentina; Massacesi, Luca | |
| Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions | 2021 | Antonio Farina, Alice Mariottini, Federica Azzolini, Claudia Mechi, Anna Maria Repice, Alessandro Barilaro, Luca Massacesi | |
| Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study | 2019 | Pasca, M; Forci, B; Mechi, C; Mariottini, A; Barilaro, A; Massacesi, L; Repice, AM | |
| CNS inflammation during relapsing remitting multiple sclerosis (RRMS): a molecular and cellular analysis of ex vivo CSF T lymphocyte expansions | 2013 | Galante, A; Bonechi, E; Mariottini, A; Aldinucci, A; Biagioli, T; Mechi, C; Repice, A; Massacesi, L; Ballerini, C | |
| Comparative efficacy of subcutaneous versus intravenous natalizumab on annualized relapse rate: a post-hoc analysis of the REFINE study | 2024 | Mariottini, Alice; Mealli, Fabrizia; Mattei, Alessandra; Massacesi, Luca | |
| Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation | 2019 | Mechi, C; Mariottini, A; Pasca, M; Forci, B; Magnani, E; Barilaro, A; Repice, AM; Massacesi, L | |
| Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing–remitting multiple sclerosis | 2024 | Mariottini, Alice; Nozzoli, Chiara; Carli, Ilaria; Landi, Filippo; Gigli, Valentina; Repice, Anna Maria; Ipponi, Alessandra; Cecchi, Michele; Boncompagni, Riccardo; Saccardi, Riccardo; Massacesi, Luca | |
| COVID-19 in patients with aggressive MS treated with aHSCT: a multi-center study | 2021 | E. Sbragia, A. Mariottini, M. Capobianco, S. Martire, L. Moiola, M.P. Amato, L. Massacesi, G. Mancardi, G. Boffa, M. Inglese | |
| Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability? | 2024 | Bellanca, Carlo Maria Maria; Augello, Egle; Mariottini, Alice; Bonaventura, Gabriele; Cognata, Valentina La; Benedetto, Giulia Di; Cantone, Anna Flavia; Attaguile, Giuseppe; Mauro, Rosaria Di; Cantarella, Giuseppina; Massacesi, Luca; Bernardini, Renato | |
| Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. | 2017 | Forci, B; Mariottini, A; Mechi, C; Massacesi, L; Repice, A. | |
| Early Morbidity of Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis- A Real World Experience | 2021 | Varun Mehra, Maria Cuadrado, Elijah Rhone, Alice Mariottini, Victoria Williams, Sarah Ware, Paolo Muraro, Antonio Pagliuca, Victoria Potter, Eli Silber, Majid Kazmi | |
| Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis | 2022 | Mariottini A, Bertozzi A, Marchi L, Di Cristinzi M, Mechi C,Barilaro A,Massacesi L,Repice A. | |
| Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation | 2023 | Alice Mariottini, Antonio Lotti, Chiara Innocenti, Anna Maria Repice , Chiara Nozzoli , Riccardo Boncompagni , Enrico Fainardi , Riccardo Saccardi, Luca Massacesi | |
| Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis | 2019 | Mariottini, A; Filippini, S; Di Tullio, MG; Forci, B; Innocenti, C; Barilaro, A; Fani, A; Saccardi, R; Massacesi, L; Repice, AM | |
| Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments | 2019 | Forci, B; Mariottini, A; Mechi, C; Magnani, E; Barilaro, A; Falcini, M; Palumbo, P; Massacesi, L; Repice, AM |